A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Clinical trial NCT02076399 · COMPLETED
Trial details
- NCT number
- NCT02076399
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-14
- Primary completion
- 2016-04-21
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.